HIV-1 infection impairs cell cycle progression of CD4+ T cells without affecting early activation responses
Open Access
- 1 September 2001
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 108 (5) , 757-764
- https://doi.org/10.1172/jci12685
Abstract
Failure of CD4+ T cells to proliferate in response to antigenic stimulation is a characteristic of HIV infection. Analysis of the proliferation defect has been hampered by an inability to identify CD4+ cells with T cell receptor specificity for antigen. To focus only on cells that had been stimulated through the T cell receptor, CD4+ T cells were stimulated with an anti-Vβ3 Ab that activates approximately 3–5% of peripheral blood T cells. This approach revealed proliferation defects in cells from HIV-infected patients that were not appreciated using anti-CD3 Ab stimulation and provided the capacity to examine responses on a single cell basis. After anti-Vβ3 Ab stimulation, CD4+Vβ3+ cells from HIV-infected patients demonstrated defects in expression of cell cycle–associated proteins, D-type cyclins, and cyclin A. However, the expression of early activation markers, CD69 and CD25, was not significantly impaired in cells from most patients. Thus, CD4+ T cell proliferation failure in HIV disease is characterized by dysregulated activation that precludes cell cycle progression. This proliferation defect was most apparent in patients with diminished CD4+ T cell numbers and higher plasma HIV RNA levels. CD4+ T cell proliferation failure may be a key determinant of immune impairment in HIV disease.Keywords
This publication has 30 references indexed in Scilit:
- Preferential S Phase Entry and Apoptosis of CD4+ T Lymphocytes of HIV-1-Infected Patients after in Vitro CultivationClinical Immunology, 2000
- Lymphocyte Proliferation Assays May Underestimate Antigen Responsiveness in Human Immunodeficiency Virus InfectionClinical Immunology, 1999
- D-type cyclinsTrends in Biochemical Sciences, 1995
- HIV‐1 glycoprotein gp120 disrupts CD4‐p56lck/CD3‐T cell receptor interactions and inhibits CD3 signalingEuropean Journal of Immunology, 1995
- T cell receptor Vβ repertoire in HIV-infected individuals: lack of evidence for selective Vβ deletionClinical and Experimental Immunology, 1993
- T-cell antigen receptor Vβ subsets are not preferentially deleted in AIDSAIDS, 1993
- Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis.The Journal of Experimental Medicine, 1992
- Programmed Death of T Cells in HIV-1 InfectionScience, 1992
- Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.The Journal of Experimental Medicine, 1992
- Helper T-cell responses in children infected with human immunodeficiency virus type 1The Journal of Pediatrics, 1991